Garmin
GRMN
276.16
-3.05
-1.09%
Garmin
US · GRMN
#414 by market cap
Listed 2000
276.16
-3.05
-1.09%
Live - 5344 symbols - heartbeat 85s ago
· 2026-10-08 06:41
Pre-market
274.99
-0.42%
After-hours
276.16
0.00%
- Market cap
- 53.26B
- P/E (TTM)i
- 28.50
- P/Bi
- 5.90
- EPSi
- 8.59
- Div yieldi
- 1.36%
- 52W posi
- 71%
Reader sentiment
Are you bullish or bearish on GRMN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 18.41, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.06% YoY
Margins
- Gross margin
- 58.74%
- Operating margin
- 25.89%
- Net margin
- 22.96%
Key ratios & quality
- PEG ratioi
- 1.46
- Altman Z-Scorei
- 18.41
PEG uses trailing P/E against the 3-year net income growth rate (19.56%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.35B | 3.76B | 4.19B | 4.98B | 4.86B | 5.23B | 6.30B | 7.25B |
| Gross profit | 1.98B | 2.23B | 2.48B | 2.89B | 2.81B | 3.00B | 3.70B | 4.26B |
| Selling & admin expenses | 633.57M | 683.02M | 721.41M | 893.09M | 944.00M | 1.01B | 1.11B | 1.25B |
| Research & development | 567.81M | 605.37M | 705.69M | 778.75M | 834.93M | 904.70M | 993.60M | 1.13B |
| Operating profit | 778.34M | 945.59M | 1.05B | 1.22B | 1.03B | 1.09B | 1.59B | 1.88B |
| Pretax profit | 823.25M | 987.22M | 1.10B | 1.21B | 1.06B | 1.20B | 1.70B | 2.01B |
| Tax | 129.17M | 34.74M | 111.09M | 124.60M | 91.39M | -89.28M | 283.97M | 350.65M |
| Net profit | 694.08M | 952.49M | 992.32M | 1.08B | 973.59M | 1.29B | 1.41B | 1.66B |
| Basic EPS | 4 | 5 | 5 | 6 | 5 | 7 | 7 | 9 |
| Diluted EPS | 3.66 | 4.99 | 5.17 | 5.61 | 5.04 | 6.71 | 7.30 | 8.59 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.54B | 1.81B | 1.77B | 2.12B | 1.75B | 2.02B |
| Gross profit | 884.55M | 1.07B | 1.05B | 1.26B | 1.04B | 1.26B |
| Selling & admin expenses | 283.60M | 318.05M | 303.22M | 349.12M | 314.81M | 342.57M |
| Research & development | 268.12M | 276.66M | 286.46M | 294.98M | 295.82M | 303.94M |
| Operating profit | 332.82M | 472.30M | 456.80M | 614.15M | 431.67M | 615.51M |
| Pretax profit | 389.08M | 480.25M | 509.82M | 635.39M | 472.53M | 651.06M |
| Tax | 56.31M | 79.43M | 108.21M | 106.71M | 67.45M | 109.14M |
| Net profit | 332.77M | 400.82M | 401.62M | 528.68M | 405.08M | 541.92M |
| Basic EPS | 2 | 2 | 2 | 3 | 2 | 3 |
| Diluted EPS | 1.72 | 2.07 | 2.08 | 2.73 | 2.09 | 2.80 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.67B | 3.06B | 3.67B | 4.26B | 3.96B | 4.46B | 5.34B | 6.25B |
| Cash & ST investments | 1.38B | 1.40B | 1.85B | 1.85B | 1.45B | 1.97B | 2.50B | 2.74B |
| Inventory | 561.84M | 752.91M | 762.08M | 1.23B | 1.52B | 1.35B | 1.47B | 1.77B |
| Total assets | 5.38B | 6.17B | 7.03B | 7.85B | 7.73B | 8.60B | 9.63B | 10.99B |
| Total current liabilities | 921.31M | 1.04B | 1.16B | 1.45B | 1.21B | 1.31B | 1.51B | 1.72B |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,219,884,000.00 | 1,373,303,000.00 | 1,515,257,000.00 | 1,740,268,000.00 | 1,526,830,000.00 | 1,591,509,000.00 | 1,782,129,000.00 | 2,021,105,000.00 |
| Total equity | 4.16B | 4.79B | 5.52B | 6.11B | 6.20B | 7.01B | 7.85B | 8.97B |
| Retained earnings | 2.71B | 3.23B | 3.75B | 4.32B | 4.73B | 5.26B | 6.00B | 6.97B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 5.45B | 5.82B | 5.81B | 6.25B | 6.00B | 6.31B |
| Cash & ST investments | 2.67B | 2.59B | 2.54B | 2.74B | 2.70B | 2.67B |
| Inventory | 1.58B | 1.79B | 1.89B | 1.77B | 1.85B | 1.97B |
| Total assets | 9.79B | 10.32B | 10.52B | 10.99B | 10.95B | 11.42B |
| Total current liabilities | 1.33B | 1.93B | 1.75B | 1.72B | 1.38B | 2.08B |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,608,144,000.00 | 2,198,965,000.00 | 2,044,637,000.00 | 2,021,105,000.00 | 1,681,414,000.00 | 2,394,878,000.00 |
| Total equity | 8.18B | 8.13B | 8.48B | 8.97B | 9.27B | 9.03B |
| Retained earnings | 6.33B | 6.04B | 6.44B | 6.97B | 7.37B | 7.11B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 919.52M | 698.55M | 1.14B | 1.01B | 788.26M | 1.38B | 1.43B | 1.63B |
| Depreciation & amortization | 96.19M | 106.18M | 126.72M | 154.82M | 163.85M | 177.57M | 179.74M | 188.76M |
| Free cash flow | 759.17M | 578.14M | 947.80M | 702.84M | 543.97M | 1.18B | 1.24B | 1.36B |
| Dividends paid | -296.15M | -417.26M | -450.63M | -491.46M | -679.10M | -558.77M | -572.36M | -663.89M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -201.01M | -98.99M | -62.35M | -181.01M |
| Ending cash balance | 1.20B | 1.03B | 1.46B | 1.50B | 1.28B | 1.69B | 2.08B | 2.28B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 420.79M | 173.17M | 485.62M | 553.79M | 535.99M | 403.56M |
| Depreciation & amortization | 46.30M | 47.11M | 49.10M | 46.25M | 49.13M | 48.86M |
| Free cash flow | 380.73M | 127.50M | 425.08M | 429.61M | 469.37M | 275.78M |
| Dividends paid | -144.57M | -173.18M | -173.17M | -172.97M | -173.64M | -202.41M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 2.18B | 2.07B | 2.07B | 2.28B | 2.29B | 2.33B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.43 | 21.27 | 19.25 | 18.61 | 15.81 | 19.52 | 19.00 | 19.78 |
| ROA %i | 13.36 | 16.49 | 15.04 | 14.54 | 12.49 | 15.79 | 15.48 | 16.14 |
| ROIC %i | 16.43 | 19.91 | 18.38 | 17.94 | 14.98 | 18.26 | 17.44 | 18.19 |
| 5-year avg ROE %i | 15.19 | 17.38 | 18.53 | 19.19 | 18.45 | 18.89 | 18.44 | 18.54 |
| EBIT margin %i | 23.25 | 25.17 | 25.18 | 24.46 | 21.15 | 20.89 | 25.31 | 25.89 |
| FCF / sales %i | 22.68 | 15.39 | 22.64 | 14.11 | 11.15 | 22.59 | 19.67 | 18.81 |
| Current ratioi | 2.89 | 2.95 | 3.15 | 2.94 | 3.26 | 3.41 | 3.54 | 3.63 |
| Quick ratioi | 2.12 | 2.04 | 2.32 | 1.86 | 1.74 | 2.12 | 2.31 | 2.32 |
| Debt / assetsi | 0.00 | 0.80 | 1.08 | 0.89 | 1.48 | 1.31 | 1.40 | 1.50 |
| LT debt / equityi | -- | 1.03 | 1.38 | 1.15 | 1.85 | 1.61 | 1.72 | 1.84 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | 5.88 | 7.25 | 10.28 | 14.18 | 8.96 | 7.69 | 8.11 | 14.24 |
| Net income CAGR (3Y) %i | 15.01 | 22.53 | 11.86 | 15.96 | 0.73 | 9.13 | 9.26 | 19.56 |
| FCF CAGR (3Y) %i | 57.05 | -1.72 | 23.03 | -2.54 | -2.01 | 7.66 | 20.80 | 35.82 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 19.04 | 20.73 | 19.66 | 19.78 | 19.90 | 21.89 |
| ROA %i | 15.94 | 16.33 | 15.81 | 16.14 | 16.74 | 17.26 |
| ROIC %i | 17.47 | 19.07 | 18.06 | 18.19 | 18.30 | 20.15 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 25.25 | 26.02 | 25.61 | 25.89 | 26.46 | 27.61 |
| FCF / sales %i | 18.87 | 16.67 | 19.19 | 18.81 | 19.45 | 20.85 |
| Current ratioi | 4.10 | 3.01 | 3.32 | 3.63 | 4.36 | 3.03 |
| Quick ratioi | 2.60 | 1.86 | 1.99 | 2.32 | 2.65 | 1.83 |
| Debt / assetsi | 1.43 | 1.44 | 1.48 | 1.50 | 1.53 | 1.56 |
| LT debt / equityi | 1.71 | 1.83 | 1.84 | 1.84 | 1.81 | 1.97 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Diversified
- Fitness is the largest reported line at 37.43% of revenue, across 5 reported segments.
- No single line clears half of revenue; Outdoor is next at 23.87%, spreading the business across more than one real driver.
Revenue breakdown most recent period
Business
Fitness37.43%
Outdoor23.87%
Marine16.88%
Aviation13.29%
Auto Original Equipment Manufacturer (OEM)8.53%
Quote time 2026-10-08 06:41:03 · For reference only, not investment advice and not tailored to your situation.